Epygen Biotech epygen.com

Epygen Biotech will be launching its entry Biosimilar molecule Recombinant Streptokinase (rSK). Its expertise on recombinant protein is utilized for purification of molecules, making them affordable for patients in the region.

Epygen Biotech will be launching its entry Biosimilar molecule Recombinant Streptokinase (rSK). Its expertise on recombinant protein is utilized for purification of molecules, making them affordable for patients in the region.

See All Exits Recent Exits

Phone:

Fax:




India

Epygen Biotech - Investments & Acquisitions

Show Real Data Epygen Biotech Investments
See all Recent Investments
Date Company Round Amount Co-investors
See all 0 investments